Wang Y., Chen J, Chen W, et al. - A systematic review and meta-analysis were performed to evaluate the literature and collate data comparing the mortality of coronavirus disease 2019 (COVID-19) patients with and without asthma. Researchers carried out to search databases PubMed, Scopus, Embase, Google Scholar, and medRxiv.org were searched for studies comparing the clinical outcomes of asthmatic patients with those of nonasthmatic patients diagnosed with COVID-19. This study included 744 asthmatic patients and 8,151 nonasthmatic patients. The results revealed that asthma as a comorbidity may not elevate the mortality of COVID-19. The results of this study indicate that data on the influence of asthma on the risk of hospitalization, the duration of hospitalization, the requirement of ICU admission, and disease severity is still too limited to draw any strong conclusions. Future trials with a larger sample size are needed to develop strong evidence.